Spivak Anna Yu, Khalitova Rezeda R, Nedopekina Darya A, Gubaidullin Rinat R
Institute of Petrochemistry and Catalysis, Russian Academy of Sciences, 141 Prospekt Oktyabrya, Ufa 450075, Russian Federation.
Institute of Petrochemistry and Catalysis, Russian Academy of Sciences, 141 Prospekt Oktyabrya, Ufa 450075, Russian Federation.
Steroids. 2020 Feb;154:108530. doi: 10.1016/j.steroids.2019.108530. Epub 2019 Oct 31.
A series of 34 new amine- and guanidine-functionalized derivatives of betulinic, ursolic, and oleanolic acids were synthesized and tested for their antimicrobial activity against the growth of four bacterial strains (Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus (MRSA)) and two fungal strains (Candida albicans and Cryptococcus neoformans). The obtained compounds were also tested for the cytotoxic effect against HEK293 human embryonic kidney cell line and hemolytic activity against human red blood cells. Most of the prepared amino and guanidinium derivatives of betulinic, ursolic, and oleanolic acids showed a considerably higher bacteriostatic activity against methicillin-resistant S. aureus than the parent compounds. The most active compounds (MICs ≤ 0.25 μg/ml or 0.4-0.5 μM) were superior over the clinically used antibiotic vancomycin in the antibacterial effect (MIC of 1 μg/ml or 0.7 μM). Apart from antibacterial activity, new triterpene acid derivatives exhibited excellent antifungal activity against Cryptococcus neoformans, with MICs values being as low as 0.25 μg/ml (0.4 μM), and were approximately 65 times as active as fluconazole, a known antifungal agent. Four most promising compounds we identified (7, 13, 24, and 33) showed not only high bacteriostatic effect, but also low cytotoxicity against mammalian HEK293 cells and high hemolytic selectivity.
合成了一系列34种新的桦木酸、熊果酸和齐墩果酸的胺基和胍基官能化衍生物,并测试了它们对四种细菌菌株(大肠杆菌、鲍曼不动杆菌、铜绿假单胞菌和金黄色葡萄球菌(耐甲氧西林金黄色葡萄球菌))以及两种真菌菌株(白色念珠菌和新型隐球菌)生长的抗菌活性。还测试了所得化合物对HEK293人胚肾细胞系的细胞毒性作用以及对人红细胞的溶血活性。大多数制备的桦木酸、熊果酸和齐墩果酸的氨基和胍盐衍生物对耐甲氧西林金黄色葡萄球菌的抑菌活性比母体化合物高得多。活性最强的化合物(最低抑菌浓度≤0.25μg/ml或0.4 - 0.5μM)在抗菌效果上优于临床使用的抗生素万古霉素(最低抑菌浓度为1μg/ml或0.7μM)。除了抗菌活性外,新的三萜酸衍生物对新型隐球菌表现出优异的抗真菌活性,最低抑菌浓度低至0.25μg/ml(0.4μM),活性约为已知抗真菌剂氟康唑的65倍。我们鉴定出的四种最有前景的化合物(7、13、24和33)不仅具有高抑菌作用,而且对哺乳动物HEK293细胞的细胞毒性低,溶血选择性高。